Eli Lilly and Johnson & Johnson have paused COVID-19 vaccine ...
Johnson and Johnson
Experts say the recent pause on COVID-19 vaccine and treatment trials aren't unusual, but rather show scientific safety processes are working.Continue reading on USA TODAY
More articles about Johnson and Johnson
Johnson & Johnson pauses its coronavirus vaccine trial because of ...
Johnson & Johnson has paused the large late-stage clinical trial of its coronavirus vaccine because of an “unexplained illness” in one of the volunteers, the ...Continue reading
2 things we know (and 3 we don't) about Johnson & Johnson and Eli ...
Johnson & Johnson announced Monday that it has halted its massive COVID-19 vaccine trial after a participant became ill. Less than 24 hours later, Eli Lilly ...Continue reading
Johnson & Johnson third-quarter sales beat expectations - CNN
Johnson & Johnson reported surprisingly strong global sales for the third quarter despite Covid-19-related headwinds.Continue reading
Johnson & Johnson pauses COVID-19 clinical trials after a ...
The drug maker said the trial was paused due to an “unexplained illness.”Continue reading
Eli Lilly and Johnson & Johnson Pause COVID Trials
Trials for Eli Lilly's antibody treatment and Johnson & Johnson's COVID-19 vaccine were both paused this week.Continue reading
Covid-19 Live Updates: White House Embraces 'Herd Immunity ...
The Midwest and West are driving a virus surge in the U.S. The Eli Lilly antibody trial is paused because of potential safety concerns, just a day after Johnson ...Continue reading
Local medical providers react to pause of Johnson and Johnson ...
Johnson and Johnson has now halted its vaccine trial after a volunteer contracted an unexplained illness.Continue reading
Johnson & Johnson coronavirus vaccine trial pause 'quite common ...
The pause on Johnson & Johnson's coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in ...Continue reading
Johnson & Johnson, Eli Lilly pause covid-19 trials for possible safety ...
The trial is the second large vaccine trial to temporarily stop giving inoculations in the United States.Continue reading
Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials
The company cited safety concerns before halting their COVID-19 vaccine candidate clinical trials, including a study of the drug therapies received by President ...Continue reading
Covid-19 Live Updates: Latest News
The Eli Lilly antibody trial is paused because of potential safety concerns, just a day after Johnson & Johnson announced the pause of its coronavirus vaccine ...Continue reading
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick ...
The company said an independent committee is reviewing the subject's illness, and it will review the medical information before deciding whether to restart the ...Continue reading
Johnson & Johnson posts strong third quarter earnings after pause ...
Johnson & Johnson reported a strong third quarter performance on Tuesday following an announcement that it is pausing its coronavirus vaccine research ...Continue reading
Johnson & Johnson coronavirus vaccine trials paused - Business ...
The pause is a setback for Johnson & Johnson's effort to prove its vaccine is safe and can prevent people from getting the coronavirus.Continue reading
Covid-19 vaccine: Johnson & Johnson pauses trial after ...
Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an "unexplained illness" in one of the volunteers testing its experimental ...Continue reading
Johnson & Johnson pauses COVID-19 vaccine trial due to ...
Johnson & Johnson's COVID-19 vaccine trial is on pause while the company investigates an illness in a participant. Pauses aren't uncommon.Continue reading
Johnson & Johnson Vaccine Trial Paused Due To 'Unexplained ...
The company said it had paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated the volunteer's illness.Continue reading
Johnson & Johnson pauses covid-19 vaccine study for 'unexplained ...
The trial is the second large vaccine trial to temporarily stop giving inoculations in the United States.Continue reading
Johnson & Johnson's coronavirus vaccine trial is paused after ...
J&J's CFO said the pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness.Continue reading
Johnson & Johnson quiere comenzar las pruebas de su vacuna ...
Johnson & Johnson anunció los planes de su vacuna contra el coronavirus y dijo que empezaría los ensayos clínicos en humanos en septiembre.Continue reading
Johnson & Johnson iniciará ensayos clínicos de vacuna contra el ...
Johnson se unirá con el Departamento de Salud y Servicios Humanos de los Estados Unidos para la creación de una vacuna contra el coronavirus.Continue reading
Johnson & Johnson probará en humanos una vacuna contra el ...
Nueva York - La farmacéutica Johnson & Johnson (J&J) anunció este lunes que comenzará el próximo septiembre a probar en humanos su vacuna ...Continue reading
Jonhson & Johnson probará en septiembre en humanos vacuna ...
Washington (AFP). La compañía farmacéutica Johnson & Johnson anunció el lunes que realizará en setiembre tests clínicos en humanos de una vacuna que ...Continue reading
Johnson & Johnson probará en humanos una vacuna experimental ...
La farmacéutica Johnson & Johnson anunció que comenzará a probar en humanos su vacuna experimental contra el coronavirus.Continue reading
Here's Why Johnson & Johnson Jumped Higher Today
The healthcare conglomerate has made substantial progress developing a vaccine for COVID-19.Continue reading
Coronavirus vaccine: Johnson & Johnson wants to start human ...
Pharmaceutical giant Johnson & Johnson plans to begin human clinical trials of its Covid-19 vaccine by September with a goal of the first batches being made ...Continue reading
Johnson & Johnson lands $1B government deal to boost ...
Johnson & Johnson said on Monday that it and the US government will invest $1 billion to create enough manufacturing capacity to make more than 1 billion...Continue reading
Johnson & Johnson stock jumps 8% after it says human testing of its ...
Johnson & Johnson said human testing of its experimental vaccine for the coronavirus will begin by September and it could be available for emergency use ...Continue reading
Johnson & Johnson Is Already Ramping Up Production On Its $1 ...
The pharma giant aims to be ready to go to market immediately once its vaccine has been tested and approved by the FDA. Its vaccine could be ready early next ...Continue reading
Johnson & Johnson partners with BARDA to fund $1 billion in ...
Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health ...Continue reading
Johnson & Johnson Ordered To Pay $572 Million In Landmark Opioid Case
Topline: A judge in Oklahoma ruled Monday that Johnson & Johnson will have to pay the state $572 million for its role in fueling the opioid crisis—the first decision in a court case attempting to hold a pharmaceutical company accountable for the spread of the ...Continue reading
Judge orders Johnson & Johnson to pay Oklahoma $572 million for fueling state's opioid crisis
An Oklahoma judge found Johnson & Johnson guilty in fueling the state's opioid crises and ordered the corporation to pay $572 million in a landmark ruling with vast implications. The ruling by Cleveland County District Judge Thad Balkman in Norman in ...Continue reading
Johnson & Johnson Is The First Drugmaker To Be Held Responsible For The Opioid Crisis
Johnson & Johnson was ordered to pay $572 million toward ending the opioid epidemic in Oklahoma, the first time a judge has found a pharmaceutical company responsible for the spike in addiction and overdoses caused by its drugs. Judge Thad Balkman ...Continue reading
Johnson & Johnson: la "histórica" sentencia que condena a la empresa a pagar US$572 millones por su papel en la ...
La farmacéutica estadounidense Johnson & Johnson (J&J) deberá pagar US$572 millones luego de que un juez de Oklahoma determinara este lunes que la compañía contribuyó a fomentar la crisis de opioides que afecta a Estados Unidos.Continue reading
Shares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fine
Shares of Johnson & Johnson rallied more than 5% on the news, resulting in a $13.5 billion market cap gain after hours. Drugmaker Teva Pharmaceutical rose 5%, while Endo International jumped 3% on the news. Mallinckrodt initially jumped 7% but gave ...Continue reading
Johnson & Johnson Ordered To Pay Oklahoma $572 Million In Opioid Trial
Updated at 7:04 p.m. ET. An Oklahoma judge has ruled that drugmaker Johnson & Johnson helped ignite the state's opioid crisis by deceptively marketing painkillers, and must pay $572 million to the state. Oklahoma sought $17.5 billion, blaming Johnson ...Continue reading
Johnson & Johnson es condenada a pagar una multa por crisis de opioides en Estados Unidos
La multinacional estadounidense Johnson & Johnson fue condenada este lunes a pagar 572 millones de dólares al estado de Oklahoma por contribuir a la adicción a los opioides, una decisión judicial histórica en Estados Unidos. (Lea: La crisis global de no ...Continue reading
Condenan a Johnson & Johnson a pagar USD 572 millones por la crisis de adicción a los opioides
La multinacional estadounidense Johnson & Johnson fue condenada a pagar una multa de 572 millones de dólares al estado de Oklahoma por su papel en la crisis de adicción a los opioides. El fallo puede tener un alcance histórico ya que podría repercutir ...Continue reading
Decision expected in landmark opioid trial against Johnson & Johnson
A ruling in a landmark legal case over the opioid crisis could lead to one of the biggest monetary awards in U.S. history. A judge in Oklahoma will decide today if Johnson & Johnson bears responsibility for helping to fuel the state's opioid epidemic by ...Continue reading
Johnson & Johnson must pay over $572 million for its role in Oklahoma opioid crisis, judge rules
An Oklahoma judge on Monday ordered Johnson & Johnson to pay over $572 million for pushing doctors to prescribe opioids while downplaying the risks of addiction, actions that state prosecutors said helped fuel the state's opioid epidemic andled to more ...Continue reading
Johnson & Johnson Ordered to Pay $572 Million in Oklahoma Opioid Case
Johnson & Johnson must pay $572 million for contributing to an opioid-addiction crisis in Oklahoma, a judge there ruled Monday in a closely watched trial. The verdict comes in the first case to go to trial of more than 2,000 brought by state and local ...Continue reading
Ordenan a la farmacéutica Johnson & Johnson pagar a Oklahoma $572 millones por su responsabilidad en la crisis de ...
La Fiscalía de Oklahoma originalmente había demandado a dos empresas más en 2017, junto a Johnson y Johnson: Purdue Pharma y la israelí Teva Pharmaceuticals. Ambas llegaron a acuerdos con la Fiscalía, que en el caso de la primera incluyó $270 ...Continue reading
Johnson & Johnson condenada a pagar USD 572 millones en juicio por opioides en EEUU
La multinacional estadounidense Johnson & Johnson fue condenada el lunes a pagar 572 millones de dólares por daños al estado de Oklahoma por contribuir a la adicción a los opioides, una decisión judicial histórica en Estados Unidos. El fallo podría ...Continue reading
Oklahoma gana un caso contra Johnson & Johnson en un histórico juicio por opioides
(CNN) — En una decisión histórica, un juez de Oklahoma ordenó este lunes al gigante farmacéutico Johnson & Johnson que pague 572 millones de dólares por su papel en la crisis de opioides del estado. El veredicto emitido por el juez de distrito del ...Continue reading
Johnson & Johnson ordered to pay $572 million for its role in Oklahoma's opioid crisis
NORMAN, Okla.— A judge Monday found Johnson & Johnson responsible for fueling Oklahoma's opioid crisis, ordering the health care company to pay $572 million to remedy the devastation wrought by the epidemic on the state and its residents. Cleveland ...Continue reading
Opioid crisis: Johnson & Johnson hit by landmark ruling
Drugmaker Johnson & Johnson must pay $572m (£469m) for its part in fuelling the opioid addiction crisis in Oklahoma, a US judge has ruled. The company said immediately after the judgement that it would appeal. The case was the first to go to trial out of ...Continue reading
Judge orders Johnson & Johnson to pay $572 million for role in opioid crisis
Oklahoma judge finds J&J fueled opioid crisis. An Oklahoma judge has found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis and ordered the consumer products giant to pay $572 million to help address the problem. (Aug.Continue reading
Oklahoma judge orders Johnson & Johnson to pay $572M in opioid suit
"Janssen did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome,” Michael Ullmann, an attorney for Johnson & Johnson said, referencing a subsidiary pharmaceutical company also named in the suit. "We recognize ...Continue reading
Johnson & Johnson fue condenada a pagar USD 572 millones por su papel en la crisis de adicción a los opioides
La multinacional estadounidense Johnson & Johnson fue condenada el lunes a pagar 572 millones de dólares por daños al estado de Oklahoma por su papel en la crisis de adicción a los opioides, una decisión judicial histórica en Estados Unidos.Continue reading
Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial
Johnson & Johnson, which contracted with poppy growers in Tasmania, supplied 60 percent of the opiate ingredients that drug companies used for opioids like oxycodone, the state had argued, and aggressively marketed opioids to doctors and patients as ...Continue reading
Judge rules against Johnson & Johnson in landmark opioid case in Oklahoma
An Oklahoma judge on Monday ruled against Johnson & Johnson in the state's opioid case, forcing the company to pay $572 million in the first ruling in the U.S. holding a drugmaker accountable for helping fuel the epidemic. Calling the opioid crisis an ...Continue reading